Ionis Pharmaceuticals’ experimental injection therapy sapablursen may ease symptoms of polycythemia vera (PV) and reduce the need for blood draws to manage the…
News
A new CAR T-cell therapy designed to target multiple myeloma while sparing healthy immune cells has been given to its first patient in a…
The U.S. Food and Drug Administration (FDA) has approved an oral drug for adults with pancreatic adenocarcinoma, the most common form of pancreatic cancer,…
Safusidenib, an experimental oral treatment for people with gliomas carrying IDH1 gene mutations, has received fast-track designation from…
Treating multiple myeloma with a Darzalex (daratumumab)-based combination may lead to a faster and longer-lasting response than a standard combination regimen using lenalidomide (sold…
Adding Moleculin Biotech’s experimental chemotherapy annamycin to the approved chemotherapy cytarabine may be more effective than cytarabine alone at controlling hard-to-treat acute myeloid leukemia…
Two clinical trials evaluating cemsidomide — an oral therapy candidate from C4 Therapeutics (C4T) that aims to limit cancer growth — in people with…
Silexion Therapeutics has launched a Phase 2/3 clinical trial testing its experimental therapy SIL204 in combination with standard-of-care chemotherapy in people with pancreatic…
The U.S. Food and Drug Administration (FDA) has granted conditional approval to iberdomide, an oral medication to be used in combination with an antibody-based…
Scientists have developed a new human cell model to study rare cases of cervical cancer that aren’t associated with human papillomavirus (HPV) infection. Few laboratory…
